Home > Press > UQ's needle free vaccine delivery research recognised
Professor Kendall |
Abstract:
University of Queensland researcher Professor Mark Kendall has been awarded the 2008 Amgen Medical Research Award for his excellence in translational medical research studies.
This national award is made annually by the Australian Society for Medical Research as part of Medical Research Week.
Professor Kendall leads a research team at the Australian Institute for Bioengineering and Nanotechnology (AIBN) developing needle-free delivery of vaccines targeting the skin.
"I am delighted and honoured with the award, it offers me great encouragement at this stage of my career," Professor Kendall said.
"Our research is focused on practical needle-free devices accurately targeting key skin cells, with the goal of clinical application of better vaccines in both the developed and developing world.
"To help optimise our delivery devices, we are performing fundamental research into the mechanical and biological properties of the skin, together with vaccine delivery studies in key disease areas."
Professor Kendall joined UQ in 2006 as a joint appointment by AIBN, the Diamantina Institute for Cancer, Immunology and Metabolic Medicine and the Faculty of Health Sciences. Prior to this he was the Associate Director of the PowderJect Centre for Gene and Drug Delivery at Oxford University, UK.
In congratulating Professor Kendall, AIBN Director Professor Peter Gray said his work typified the research excellence to be found at the AIBN.
"Mark's work is multidisciplinary in nature, combining vaccine science, bioengineering together with biomaterials and microfabrication, and it typifies AIBN's dynamic research environment and industry focus," Professor Gray said.
Director of the Diamantina Institute Professor Ian Frazer said that Professor Kendall's work was an important collaboration between the Institutes.
"This collaborative project offers great hope in reducing the estimated 14 million deaths caused each year by infectious diseases and, due to its robustness and efficiency, could be of particular benefit in developing countries," Professor Frazer said.
The AIBN is a multi-disciplinary research institute based at UQ, which brings together the skills of world-class researchers in the areas of bioengineering and nanotechnology to produce positive health and environmental outcomes such as biomedical delivery; bio-devices; tissue regeneration; and cell therapies.
####
For more information, please click here
Contacts:
Professor Mark Kendall
0431 162 391
or
Russell Griggs
07 3346 3989
Copyright © University of Queensland
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||